Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia.

Saved in:

Bibliographic Details
Title:	Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia.
Authors:	Bridges DJ; PATH-Malaria Control and Elimination Partnership in Africa (MACEPA), National Malaria Control Centre, Chainama Hospital College Grounds, Lusaka, Zambia. dbridges@path.org., Miller JM; PATH-Malaria Control and Elimination Partnership in Africa (MACEPA), National Malaria Control Centre, Chainama Hospital College Grounds, Lusaka, Zambia., Chalwe V; Zambia Ministry of Health, Provincial Medical Office, Mansa, Luapula Province, Zambia., Moonga H; National Malaria Control Centre, Zambia Ministry of Health, Chainama Hospital, Lusaka, Zambia., Hamainza B; National Malaria Control Centre, Zambia Ministry of Health, Chainama Hospital, Lusaka, Zambia., Steketee R; PATH-Malaria Control and Elimination Partnership in Africa (MACEPA), 2201 Westlake Avenue, Seattle, WA, USA., Silumbe K; PATH-Malaria Control and Elimination Partnership in Africa (MACEPA), National Malaria Control Centre, Chainama Hospital College Grounds, Lusaka, Zambia., Nyangu J; PATH-Malaria Control and Elimination Partnership in Africa (MACEPA), National Malaria Control Centre, Chainama Hospital College Grounds, Lusaka, Zambia., Larsen DA; Syracuse University Department of Public Health, Food Studies and Nutrition, Syracuse, NY, USA.
Source:	Trials [Trials] 2017 Nov 02; Vol. 18 (1), pp. 511. Date of Electronic Publication: 2017 Nov 02.
Publication Type:	Comparative Study; Journal Article; Randomized Controlled Trial
Journal Info:	Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1745-6215
DOI:	10.1186/s13063-017-2249-0